MoonLake Immunotherapeutics (MLTX)
18.22
+0.11%
MoonLake Immunotherapeutics (MLTX) is currently trading at $18.22. This represents a gain of 0.11% from the previous session. With a market capitalization of $1.30B, MLTX is a key component of the Health Care sector. Investors looking to trade MLTX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade MLTX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, MoonLake Immunotherapeutics (MLTX) shows a bullish trend. Analysts are watching the 19.00 level closely.
Fundamentals
Mkt Cap1.30B
P/E Ratio0.0000
Volume1,349,585
60-Day Technical Chart
Advanced Charting
Need more indicators for MLTX? Use the world's #1 platform.
Open MLTX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $18
| Metric |
MLTX +0.11% |
SOFI +3.38% |
HPQ +0.05% |
KVUE -1.26% |
|---|---|---|---|---|
| Price | $18.22 | $19.29 | $18.21 | $18.77 |
| Mkt Cap | $1.30B | $24.66B | $16.72B | $35.98B |
| - | View → | View → | View → |
Latest Headlines
MLTX Stock Jumps Over 10% Overnight As Spine Drug Trial Win Sets Stage For Investor Day Showdown
Stocktwits • Feb 22, 2026
MLTX: Oppenheimer Maintains 'Outperform' Rating, Raises Price Ta
GuruFocus • Feb 24, 2026
Why Is MoonLake Immunotherapeutics Stock Trading Higher Today - MoonLake (NASDAQ:MLTX)
Benzinga • Feb 23, 2026
New Analyst Forecast: $MLTX Given $30 Price Target
Quiver Quantitative • Feb 24, 2026
MoonLake Catapults On FDA Deal For Its Down-And-Out Skin Disease Drug
Investor's Business Daily • Jan 8, 2026
● Gemini Agentic AI Analyst Insight for MLTX
Market Education
- Want to be a Wall street billionaire, take their investing advice Jul 19, 2023
- Santa Rally: What It Is and How It Affects the Stock Market Dec 10, 2024
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
External Research